Health Exec caught up with Erik Swanson, senior vice president of data and analytics at Kaufman Hall, to learn more about the underlying trends throughout 2022 and what hospitals are bracing for in 2023.

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association, include staving off the large Medicare reimbursement cuts, continuation of telehealth reimbursements, and revamping prior authorizations. 

The FDA has cleared software that automatically assesses density of breast tissue on mammography.

Researchers have identified new details about the link between certain cancer therapies and heart complications. Could their work lead to key improvements in patient care?

MRI scanner OEMs will soon face increased pressure to differentiate machines in their R&D pipelines with superconducting magnets, open designs, AI integrations and—maybe most challenging—potential for portability.

An estimated 3.2 million excess deaths and 18.5 million hospitalizations have been prevented due to COVID-19 vaccines, the Commonwealth Fund found.

Prior to the Dec. 15 announcement, CMS had released a different statement in June informing the public that they were reconsidering the amount of PET scans that Alzheimer’s patients undergoing monoclonal antibody treatment can receive.

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.